Pancreaticobiliary cancer: The future aspects of medical oncology
Open Access
- 1 August 1999
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 10, S296-S299
- https://doi.org/10.1093/annonc/10.suppl_4.s296
Abstract
Pancreatic cancer is one of the most common and most lethal cancers in the Western world with a median survival of approximately 3 months. Thus far, the results of anti-cancer treatment have been dismal, with a median survival of only 20 months in resectable pancreatic cancer, and 6 months in advanced disease. Although combined chemoradiation results in improved local control, it has only a modest impact on survival due to the development of distal metastases. In this review we will discuss the progress made in the treatment of pancreatic cancer over the past few years and discuss future therapies such as: immunoradiotherapy, matrix metalloproteinase inhibitors, anti-angiogenesis therapies, gene therapy, immunotherapy, ONYX-015, and farnesylation inhibitors.Keywords
This publication has 24 references indexed in Scilit:
- Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma.Journal of Clinical Oncology, 1998
- ESPAC-1 Trial Progress Report: The European Randomized Adjuvant Study Comparing Radiochemotherapy, 6 Months Chemotherapy and Combination Therapy versus Observation in Pancreatic CancerDigestion, 1997
- Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic headThe American Journal of Surgery, 1996
- Adjuvant therapy for pancreatic cancerBritish Journal of Surgery, 1995
- Neoadjuvant Therapy for Unresectable Pancreatic AdenocarcinomaArchives of Surgery, 1993
- Resection Margins in Carcinoma of the Head of the PancreasAnnals of Surgery, 1993
- Treatment of Locally Unresectable Carcinoma of the Pancreas: Comparison of Combined-Modality Therapy (Chemotheraphy Plus Radiotherapy) to Chemotheraphy Alone1JNCI Journal of the National Cancer Institute, 1988
- Cancer of the pancreas: 50 years of surgeryCancer, 1987
- Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study.Journal of Clinical Oncology, 1985
- Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. The gastrointestinal tumor study groupCancer, 1981